ClinicalTrials.Veeva

Menu

COmbining Oral Letrozole and Clomiphene for Ovarian Stimulation (COOL-COS)

U

University of Sao Paulo

Status and phase

Completed
Phase 4

Conditions

Infertility

Treatments

Drug: COOL-COS

Study type

Interventional

Funder types

Other

Identifiers

NCT02288143
CAAE 37537014.6.0000.5440

Details and patient eligibility

About

This is a pilot study evaluating the effect of a simplified low-cost (friendly) controlled ovarian stimulation using clomiphene citrate, letrozole, and low-dose hMG on the number of oocytes retrieved.

Enrollment

28 patients

Sex

Female

Ages

18 to 40 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Women scheduled to controlled ovarian stimulation for oocyte retrieval.
  • Body mass index: 18-35 Kg/m2.
  • Ultrasound scan up to the third day of a menstrual cycle with absence of a dominant and active follicle (follicle >10mm and serum estradiol ≥ 40 pg/L).
  • Signing an informed consent.

Exclusion criteria

  • No exclusion criteria.

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

28 participants in 1 patient group

COOL-COS
Experimental group
Description:
All women will receive the intervention: Letrozole, Clomiphene, and low-dose hMG for the controlled ovarian stimulation.
Treatment:
Drug: COOL-COS

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems